Skip to content
Log in
Sponsored AI Networking Cookbook: Practical recipes for AI-assisted network automation and development AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
Review

Statin Therapy for Cardiovascular Disease Prevention in People Living with Human Immunodeficiency Virus: A Systematic Review of Efficacy, Safety, and Clinical Challenges

Wajan Alqathanin Renad Albalawi Nouf Falah Shahad Alamri W. Alotaibi Badriah Alqahtani RA Alnemary Noura Almotrib Fatima Al-otaibi Noura Al-Amro S. Alshehri Refal Mansour A. Khan M. Kanan
· 0 citations · 73 references

TL;DR

Clinically, pitavastatin reduced serious cardiovascular events by 35% compared to placebo in a trial of >7,700 PLWH aged ≥40 years on ART, supporting its broader preventive use.

Semantic Scholar
View source

Similar papers

Review Open access Aug 2026

Beyond Lipid Lowering: A Narrative Review and Expert Perspective on Precision Cardiovascular Prevention in People with HIV After REPRIEVE

Current understanding of atherosclerosis pathogenesis in individuals with HIV is reviewed, focusing on recent findings from the REPRIEVE trial, and current approaches to improving cardiovascular risk assessment across clinical, biological, and computational levels are outlined.

P. Domingo, P. Prieto · 0 citations
Review Open access Sep 2026

Mortality and Cardiovascular Outcomes Associated with Statin Use in Dialysis Patients with Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.

INTRODUCTION Dialysis patients with established atherosclerotic cardiovascular disease (ASCVD) face exceptionally high risks of mortality and recurrent cardiovascular events, yet remain substantially underrepresented in major statin trials. We aimed to synthesize evidence from studies restricted to this population to e...

K. Chienwichai, Pannawat Mongkolrattanakul, Arunchai Chang et al. · 0 citations
Review Open access Sep 2026

Residual atherosclerotic cardiovascular disease risk in statin-treated patients: mechanisms, therapeutic strategies, and future directions—a scoping review

Background Statins remain the cornerstone of pharmacological prevention for atherosclerotic cardiovascular disease (ASCVD) because of their proven ability to reduce low-density lipoprotein cholesterol (LDL-C) and major adverse cardiovascular events (MACE). However, many patients continue to experience ASCVD events desp...

Muhammad Abdul Rehman, M. O. Oduoye, D. J. Ozoemena et al. · 0 citations
Open access Aug 2026

The Complex Interplay Between Dyslipidemic Subjects Living with Type 2 Diabetes and Metabolic Syndrome and Statin Treatment: A Reflection on Adherence and Persistence in the Real World

High levels of blood cholesterol are a major risk factor for atherosclerotic cardiovascular disease and require early and consistent utilization of statins as first-line medications to avoid disabling or even deadly consequences. Nevertheless, real-world treatment adherence is significantly lower than that reported in...

F. Strollo, G. Guarino, Ersilia Satta et al. · 0 citations
Review Open access Oct 2026

Impact of Evolocumab on LDL‐Cholesterol and Cardiovascular Outcomes in Patients With Established CVD: Systematic Review and Meta‐Analysis

ABSTRACT Background Atherosclerotic cardiovascular disease is a leading cause of morbidity and mortality, and many high‐risk patients fail to reach LDL‐cholesterol (LDL‐C) targets on statins alone. Evolocumab, a PCSK9 inhibitor, offers potent LDL‐C lowering, but a synthesis of its lipid and clinical benefits in seconda...

Anika Goel, M. Naveed, H. Tandel et al. · 0 citations
Review Open access Sep 2026

Efficacy and Safety of Oral Non‐Statin Lipid‐Lowering Therapies in Dyslipidaemia: A Systematic Review and Network Meta‐Analysis

ABSTRACT Introduction Dyslipidaemia remains a major contributor to atherosclerotic cardiovascular disease (ASCVD), and many patients fail to achieve recommended low‐density lipoprotein cholesterol (LDL‐C) targets despite statin therapy or are unable to tolerate statins. Oral non‐statin therapies have emerged as importa...

Tamer Hodrob, Reem J. Saad, Aya Hamdy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.